Cancer Discovery

Shares of TrovaGene Inc (NASDAQ: TROV), a molecular diagnostic company, gained more than 2 percent on Friday after the company announced that it was favorably mentioned in a medical journal. TrovaGene said a patient case report feature use of its Precision Cancer Monitoring technology was...